To provide long-term capital growth through investment primarily in a growth style biased portfolio of UK companies.
Name | % Net Assets |
---|---|
Royal Dutch Shell | 8.9% |
BP | 7.9% |
Vodafone | 5.8% |
GlaxoSmithKline | 4.9% |
BG | 3.3% |
AstraZeneca | 3.2% |
British American Tobacco | 3.0% |
Tesco | 2.5% |
Diageo | 2.0% |
Reckitt Benckiser | 1.8% |
Key | % Net Assets |
---|---|
Royal Dutch Shell | 8.9% |
BP | 7.9% |
Vodafone | 5.8% |
GlaxoSmithKline | 4.9% |
Other | 72.5% |
Date | 09-Sep-2022 |
---|---|
NAV | 151.60p |
Currency | GBP |
Change | 2.60p |
% | 1.74% |
YTD change | 151.60p |
YTD % | n/a |
Fund Inception | 18/12/2008 |
---|---|
Fund Manager | n/a |
TER | 1.68 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research